• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM28 介导的 NUP37 积累增强脂质合成,从而加速 HCC 进展。

NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression.

机构信息

Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Research Center of Digestive Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.

出版信息

Oncogene. 2024 Oct;43(44):3255-3267. doi: 10.1038/s41388-024-03167-1. Epub 2024 Sep 18.

DOI:10.1038/s41388-024-03167-1
PMID:39294431
Abstract

Elevated intracellular lipid synthesis is important for hepatocellular carcinoma (HCC) progression. Our study aimed to identify the role of nucleoporin 37 (NUP37) in lipid synthesis and HCC progression. The expression of NUP37 was significantly upregulated in HCC and associated with a poor prognosis. NUP37 silencing suppressed lipid synthesis, proliferation, migration, and invasion of HCC cells in vitro, and restrained tumor growth in xenograft mouse models in vivo. Next, we found the high expression of NUP37 in HCC was related to post-translational modifications. Tripartite motif-containing 28 (TRIM28) was identified as an interacting protein of NUP37 and upregulated its protein level. The subsequent analysis revealed that TRIM28-mediated SUMOylation of NUP37 at Lys114/118/246 inhibited K27-linked polyubiquitination of NUP37, which is one reason for its high expression level in HCC. In conclusion, TRIM28 SUMOylates NUP37 to prevent its ubiquitination and proteasomal degradation, increasing the stability of the NUP37 protein, thereby promoting lipid synthesis and the progression of HCC.

摘要

细胞内脂质合成升高对肝细胞癌(HCC)的进展很重要。我们的研究旨在确定核孔蛋白 37(NUP37)在脂质合成和 HCC 进展中的作用。NUP37 的表达在 HCC 中显著上调,并与预后不良相关。NUP37 沉默抑制 HCC 细胞在体外的脂质合成、增殖、迁移和侵袭,并在体内异种移植小鼠模型中抑制肿瘤生长。接下来,我们发现 HCC 中 NUP37 的高表达与翻译后修饰有关。三结构域含 28 (TRIM28)被鉴定为 NUP37 的相互作用蛋白,并上调其蛋白水平。随后的分析表明,TRIM28 介导的 NUP37 在 Lys114/118/246 处的 SUMO 化抑制了 NUP37 的 K27 连接多泛素化,这是其在 HCC 中高表达的原因之一。总之,TRIM28 对 NUP37 进行 SUMO 化,以防止其泛素化和蛋白酶体降解,从而增加 NUP37 蛋白的稳定性,从而促进脂质合成和 HCC 的进展。

相似文献

1
NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression.TRIM28 介导的 NUP37 积累增强脂质合成,从而加速 HCC 进展。
Oncogene. 2024 Oct;43(44):3255-3267. doi: 10.1038/s41388-024-03167-1. Epub 2024 Sep 18.
2
TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.TRIM52 在肝癌细胞中的上调通过泛素化 PPM1A 促进增殖、迁移和侵袭。
J Exp Clin Cancer Res. 2018 Jun 13;37(1):116. doi: 10.1186/s13046-018-0780-9.
3
Tripartite motif 8 promotes the progression of hepatocellular carcinoma via mediating ubiquitination of HNF1α.三结构域蛋白 8 通过介导 HNF1α 的泛素化促进肝细胞癌的进展。
Cell Death Dis. 2024 Jun 15;15(6):416. doi: 10.1038/s41419-024-06819-y.
4
ZMAT2 condensates regulate the alternative splicing of TRIM28 to reduce cellular ROS accumulation, thereby promoting the proliferation of HCC cells.ZMAT2 凝聚物调节 TRIM28 的可变剪接,减少细胞内 ROS 积累,从而促进 HCC 细胞的增殖。
Cell Commun Signal. 2024 Aug 20;22(1):407. doi: 10.1186/s12964-024-01790-9.
5
Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients.增强子去甲基化上调 MCM2 和 NUP37 的表达,预测肝癌患者预后不良。
J Transl Med. 2022 Jan 29;20(1):49. doi: 10.1186/s12967-022-03249-2.
6
Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.泛素特异性蛋白酶2a通过去泛素化和稳定RAB1A促进肝细胞癌进展。
Cell Oncol (Dordr). 2021 Apr;44(2):329-343. doi: 10.1007/s13402-020-00568-8. Epub 2020 Oct 19.
7
TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.TRIM31 在肝细胞癌中上调,并通过诱导 TSC1-TSC2 复合物的泛素化来促进疾病进展。
Oncogene. 2018 Jan 25;37(4):478-488. doi: 10.1038/onc.2017.349. Epub 2017 Oct 2.
8
HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA.HNF4A-AS1 通过促进 PCBP2 的泛素修饰降解和抑制 ARG2 mRNA 的稳定性来抑制肝细胞癌的进展。
Int J Biol Sci. 2024 Sep 23;20(13):5087-5108. doi: 10.7150/ijbs.95276. eCollection 2024.
9
Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.尿苷-胞苷激酶 2 的上调预示着肝细胞癌的预后不良,并且与癌症的侵袭性有关。
Mol Carcinog. 2019 Apr;58(4):603-615. doi: 10.1002/mc.22954. Epub 2019 Jan 22.
10
UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.UBE2S 在核内与 TRIM28 相互作用,通过泛素化 p27 来加速细胞周期,从而促进肝细胞癌的发展。
Signal Transduct Target Ther. 2021 Feb 16;6(1):64. doi: 10.1038/s41392-020-00432-z.

引用本文的文献

1
DDX39B K63-linked ubiquitination mediated by TRIM28 promotes NSCLC metastasis by enhancing ECAD lysosomal degradation.由TRIM28介导的DDX39B K63连接的泛素化通过增强E-cadherin溶酶体降解促进非小细胞肺癌转移。
Signal Transduct Target Ther. 2025 Jul 16;10(1):221. doi: 10.1038/s41392-025-02305-9.
2
Exploring NUP62's role in cancer progression, tumor immunity, and treatment response: insights from multi-omics analysis.探索NUP62在癌症进展、肿瘤免疫和治疗反应中的作用:来自多组学分析的见解
Front Immunol. 2025 Mar 3;16:1559396. doi: 10.3389/fimmu.2025.1559396. eCollection 2025.

本文引用的文献

1
Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation.泛素连接酶 NEDD4 通过靶向 PCDH17 蛋白进行泛素化和降解促进肝癌细胞的增殖。
J Biol Chem. 2024 Jan;300(1):105593. doi: 10.1016/j.jbc.2023.105593. Epub 2023 Dec 23.
2
TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance.TRIM28 通过增加 PD-L1 丰度促进胃癌细胞逃避免疫监视。
Signal Transduct Target Ther. 2023 Jun 26;8(1):246. doi: 10.1038/s41392-023-01450-3.
3
Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.
MORC2 的动态 SUMOylation 协调了染色质重塑和 DNA 修复,以响应 DNA 损伤,并在乳腺癌中驱动了化疗耐药性。
Theranostics. 2023 Jan 22;13(3):973-990. doi: 10.7150/thno.79688. eCollection 2023.
4
TRIM28 protects CARM1 from proteasome-mediated degradation to prevent colorectal cancer metastasis.TRIM28保护CARM1免受蛋白酶体介导的降解,以防止结直肠癌转移。
Sci Bull (Beijing). 2019 Jul 30;64(14):986-997. doi: 10.1016/j.scib.2019.05.024. Epub 2019 May 25.
5
Evolving therapeutic landscape of advanced hepatocellular carcinoma.晚期肝细胞癌不断演变的治疗格局。
Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11.
6
HOIP modulates the stability of GPx4 by linear ubiquitination.HOIP 通过线性泛素化调节 GPx4 的稳定性。
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2214227119. doi: 10.1073/pnas.2214227119. Epub 2022 Oct 24.
7
Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin.SUMOylation 和泛素化之间的串扰通过维持染色质上的 MRE11 稳态来控制 DNA 末端切除。
Nat Commun. 2022 Sep 1;13(1):5133. doi: 10.1038/s41467-022-32920-x.
8
SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.SOCS2 增强的 SLC7A11 泛素化促进肝癌中的铁死亡和放射增敏作用。
Cell Death Differ. 2023 Jan;30(1):137-151. doi: 10.1038/s41418-022-01051-7. Epub 2022 Aug 22.
9
Signalling mechanisms and cellular functions of SUMO.SUMO 的信号机制和细胞功能。
Nat Rev Mol Cell Biol. 2022 Nov;23(11):715-731. doi: 10.1038/s41580-022-00500-y. Epub 2022 Jun 24.
10
Lipid alterations in chronic liver disease and liver cancer.慢性肝病和肝癌中的脂质改变。
JHEP Rep. 2022 Mar 26;4(6):100479. doi: 10.1016/j.jhepr.2022.100479. eCollection 2022 Jun.